MedPath

The Safety and Efficacy Evaluation of Hair Products Containing Probiotics

Phase 2
Completed
Conditions
Skin Problems
Interventions
Combination Product: Placebo group
Combination Product: Test group Probiotic Shampoo
Registration Number
NCT04566549
Lead Sponsor
GenMont Biotech Incorporation
Brief Summary

Previous studies on skin health with Lactic acid bacteria (LAB) have been published for many years, including prevention of skin diseases and improvement of skin conditions. In this clinical study, the investigators researched the benefit effects of heat-killed Lactobacillus paracasei shampoo on scalp and hair healthcare.

Detailed Description

To evaluate the safety and efficacy of hair products containing probiotics

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
21
Inclusion Criteria
  • Healthy volunteers between the ages of 20-70.
Exclusion Criteria
  • Subjects are undergoing medical therapy for scalp, hair diseases or diabetes mellitus.
  • Subjects with cosmetics allergy.
  • Subjects had accepted the scalp surgery such as Follicular Unit Transpalnt, Follicular Unit Extraction in the past half year.
  • Subjects with pregnancy or breast-feeding.

Study & Design

Study Type
INTERVENTIONAL
Study Design
CROSSOVER
Arm && Interventions
GroupInterventionDescription
Placebo groupPlacebo groupShampoo base without probiotics inculding Aqua、Sodium Lauryl Ether Sulphate、Cocamidopropyl Betaine、Cocoamide DEA、Sodium、Polyquaternium-10 、Disodium EDTA、Acrylates Copolymer、Citric Acid、Phenoxyethanol、Fragrance.
Test groupTest group Probiotic ShampooShampoo base with probiotics inculding Aqua、Sodium Lauryl Ether Sulphate、Cocamidopropyl Betaine、Cocoamide DEA、Sodium、Polyquaternium-10 、Disodium EDTA、Acrylates Copolymer、Citric Acid、Phenoxyethanol、Fragrance、Heat-killed Lactobacillus paracasei powders (5x10\^8 cells/ g-shampoo).
Primary Outcome Measures
NameTimeMethod
Skin MicrobiotaBaseline, 4 weeks and 8 weeks

The changes of scalp microbiota will be evaluated by NGS or qPCR analysis at baseline and different timepoint post-intervention.

Secondary Outcome Measures
NameTimeMethod
The scalp flakes (dandruff)Baseline, 2 weeks, 4 weeks, 6 weeks, 8 weeks, 12 weeks, 20 weeks and 28 weeks

The scalp flakes will be evaluated by D-SQAME ® DANDRUFF TESTER at baseline and different timepoint post-intervention.

The sebum on scalpBaseline, 2 weeks, 4 weeks, 6 weeks, 8 weeks, 12 weeks, 20 weeks and 28 weeks

The scalp sebum will be measured by Sebumeter SM815 (C+K, Germany) at baseline and different timepoint post-intervention.

Adverse EventBaseline and 28 weeks

Any adverse event, such as erythema,rash, itching and so on will be recorded during the intervention.

The hair density (hairs/scalp area)Baseline, 4 weeks, 8 weeks, 12 weeks, 20 weeks and 28 weeks

The hair number in a constant scalp area will be measured by Aramo TSII skin/hair diagnosis (Aramhuvis Co., Ltd. Korea) at baseline and different timepoint post-intervention.

Single application closed patch epicutaneous test under occlusion1 hour, 24 hours and 48 hour

Probiotics on skin will be evaluated by Human Patch test. The Human Patch test method according to the Guidelines of Human Patch test Standards for Cosmetics, Taiwan Food and Drug Administration, 2019 edition.

Repeated application closed patch epicutaneous test under occlusionDay 1, 2, 3, 4 and 5

The irritation potential of probiotics on skin will be evaluated by Human Patch test.

The Human Patch test method according to the Guidelines of Human Patch test Standards for Cosmetics, Taiwan Food and Drug Administration, 2019 edition.

Trial Locations

Locations (1)

Chia Nan University of Pharmacy and Science

🇨🇳

Tainan, Taiwan

© Copyright 2025. All Rights Reserved by MedPath